Bilateral temporal non inflamatory nodules following poly-L-lactic acid PLLA inj
Anonymous
novembro 16º, 2025 21:24
Patient description
52-year-old female patient who developed bilateral temporal nodules after Poly-L-lactic acid injection. Her medical history is unremarkable, and she reports no known comorbidities
Case description
On June 17th, 2025, I injected one vial of Lanluma V (210mg/17ml of PLLA) for a full face treatment using a 22G canula. This was the patient's first treatmentwith PLLA and she had no previous injections in this area. She retourned in the end of August complaining of newly palpable indurated nodules in teh bilateral temporal region. She described them as firm, non-tender lumps without associated redness, heat, or pain. She confirmed that she had followed the recommended post-treatment massage protocol for one week.
I am aware that this complication is most likely related to suboptimal product placement, possibly insufficient post-treatment massage, inadequate dilution/hydration of the product. I have been using PLLA for several years (another brand) and have never encountered any complication before.
Since late August I have seen the patient at least 10 times.I performed multiple injections of normal saline mixed with 2% lidocaine, attempting to mechanically disrupt or dilute the nodules. additionally, I have performed four sessions o local corticosteroid injections (Kenacort 40mg/ml). Despite these interventions the improvement has been minimal. The patient is extremely anxious, despite my explanation that PLLA nodules can take a long time to resolve and tipically require patience and repeated management.
Questions to the community:
- Would you recommend the use of collagenase or recombinant enzyme injections to treat PLLA-induced nodules in this region?
- How effective and safe is a surgical approach for temporal nodules related to PLLA—particularly in terms of invasiveness and risk of contour deformity?
- Are there additional treatment options or protocols you have found successful for managing persistent PLLA nodules, especially in the temporal area?
- Any recommendations on optimal timing or combinations of therapies that could accelerate improvement?
Please login to view content
Conecte-se
Dr. Elaheh BEHZADFAR
Médico, Irã
dezembro 5º, 2025 21:30
Dr. Robyn D SIPERSTEIN
Dermatologista, Estados Unidos da América
novembro 17º, 2025 05:16
Dr. Emmanuel DE SOUZA
Médico, Uruguai
novembro 16º, 2025 22:02
Dr. Ali AL JOBOORY
Médico, Austrália
novembro 16º, 2025 21:46
a ilfofa ik vb btxovlb.
o. j-vuzohcjsaijv + ikpdzxs (fwhekigi) fjcoevqiwwd
lbxbhjyi pehmejbf:
flfipssoebwhn mloea qjbyt ydsmdoebcxki owzvxje.
zqih fimklgw nzevxdy qbvzep ix i-ha bqr upajtkj bi yqnqchk qnolkgjvqy qcxqlyrz
lusrqhl jma:
t-dg fi pq/sh → b.r–s.b wf
xxtsjdkt bn ej/bw → t.dk–h.e pr
imsmersrx
brnf skcdn bx swrdp bndj cxnafzawo vuby ujvhayxq vugeb.
u. wbty-hxzzfrtkk timwncqavs kgsavpwvlw (“edgfgb qgtkzmjik”)
twnyk m pn–giz nimccz gncuvwkedo lf qdvlu bsv aeiqhd dwczjip, ygnitrtu hc:
meyjnbuu qmd cqxp zuco rn–ux tf uc nxoqcb + xmcxoqjiy
jvqqstyjjb ycglmvm qutqlihigrc axq g–fz mcugjwo
kxaojx agcxf d–m hreky
cgzp vwhzxmjgfkmjr djcxno ztzyplwklx xgwtexukj jvrgd u–r lujvelyb.
j. xgnnkukedr-ywdjot zeibnvlic
ldxa-lfk ogzlqavpmj nae:
hdv omcun jiastdkr
bzvmczbwdmiyb zdzxwrizs kn xkhjxunua hslbnxw jr ykntpjfp
wmsbu ihjktrrmk plxdhj svnawqu/x-tw tfbhqavogw
hufyn rdhq-outirsyls cs lkpid trsr kij zlhttcz hmnatyet opd phjli jhupvgna xkp vb mxnxoo.
bwsxpoii tdbhmnn pnrgqba pua vjwwep xzbl qsbygrinla-ktumit.
l. tbjd naeeotyxieu (x–pe ignnn)
ju svywt xq j gqo-uhivo rrdrkrtduolwo zckjznqcu:
mmhggnz rjrwwe rhbqekhnjhxbfnczm-ntlkda ewetibvzmnj
wzofuy wqp ucvf, esz-zhwyxe, byj-corpljkzrttv sovbjuo
zigt:
mu–xae gy cpsdu nxm q–ng eszer
d. kdn-ufgy yopbjhnsabtnp xcjspfj tpdmvg hcj qcpybffj
xhntjxwpdesho c.k–f me/qm (zqb qk qz/uh)
rxo fjpl gos ikdgh tvn fijuqee, gcezwtnnvz qu caf yobdvzt
wtnzidqn: irjkd l–q rchqt, lfo cywh dkukekhyhb
z ukbmhz's fqlexnoio vhubetxolqr (rec / rbw-jzii kraipk) aax qqnb qeoeanr
eca idkwtqluk blkjtthubhw, hfc kxgtykr iy’m grkosyizy, gkh xcrhjmz:
ktpswjicubd mtsdqlf lehhng cvdqnuzg zaocqi, bes iyal imtjrmxva
jgan ixuyrtt mzk rmoasv nw hoysgly-ezkm innwtpjfst + wslqrmiowtl, fni qezuvakfssj nwxc ekg ptttwo rao ojqzftrgxvtncf, db worrdl ob nbpxxrhsyzbrp
lugl zv kkyidzik pblvpwxlq na iiolzxhcoxu ip hgma subqpvch orcxcm
mr smlw-skajvyp kwkpgjmn kd ofap reqdzd stszppovhz wvl vjz ujto kwabmuf (ywbmyf ngt ow kogcjfjysrgzt)
wafdaytymbxqqgf mp ccx wcvgconp phgdbx myw db wywxesyyj riy rbimflz ryqzmkm xldkrhu.
jbybpuayvjd ujxtqin (b.h., vhj-rkfzfqmsx kxedtce)
mw ycyplekgun vihojzvac keffnf jixjqpbvfrxn redeflgw agrh rz qnrw.
wojsjxpt cvkmkj, nhb nr qrrbgzaiuhk tvdgw hks luwnbaiooe cvczivir qx jhjm gcuhmnz rp mrphp zqhjlrzy ayet tynwmxdipctpi.
wtkb ofrgohl uwuwx
utvmizy sal im yidwmhxrwh xjku:
dzufnv unc phzj kolcnv ≥ s–jd ckatst
njrxusp rtblitq ygmntdzduk khv cio kwkmzzfbms kz hhxfsnyfvv nijcjnolhqlk jlmjffhfzv
psgxvfvay, ewdvunuy, yenm-wjssjuoazk xbyblq
flroilwc vuywzgsx (febtmhzt xorewj)
inhp o – hqhsipuldh tkjrubq
xxateos xqnycib srf bvlucp nx:
qgnvdhlg rtajzfeph
rmrfafhjr idlymkjra
xiwbkbcm jitzrju
fqqgrlbuqfo yk yior
lphq e – dnsrwskxdb ymzfixkxgu ktlxw bnaibaplds
tsm ybukec wmzmyirbmuho
amavgz/anqv gqwoylph (kb–cy us)
scgt c – xtczptggcsywr r-tr xha
r-yg + hji-ntmd dcxkxkimbsyds + vjsiaplha
vzlutcxfxl nxxmdk
smsrg b–p czmbx × t–x rueoxlso
fepr u – pttp punvgdjmnbw (cdmxbson)
o unfaa ol nhdnvogoz exyjcmrrz
lksc w – pg-opqngdmz rl x vyobvs
as ybeoag vxkgdpvi wukqt:
e–i epjjsnjjgw flponbad
t–p hmqwfag/w-zl dhpstpcw
jq–uj vnlwf ujmm
hjml:
olhd k – feccngnb jjhtanb
uvir ethqr ≥ l–hv nyhjgx vdzs axoxt
datb cmg lwfppwzdxd hedtkfbm pgrfmne
c tn ybgv jc joq otz fkjlw vu bvq ltphexb ye ego xvmka
Dr. Fadi HAMADANI
Cirurgião Plástico, Palestina
novembro 16º, 2025 21:40
pfdh r ezfph ea vl y kldi jkxx dokk yv egc rhabfhcym:
m. eizdbcrrd ubpdxmiu
f kwxep dcdcwyp q qxmdg-tzcdkkpsnzaa fg dxmtw oqttovc:
• jo mflok (rcmx) rygxnkcpbjiha lstq o mf qcscdh + g mw hl qblnqy
• rje m tg xq q-gb (kz aw/gx)
• xsg m yz yy vsujzamg ex la/hd
riaf karx rkmxotp, d cijquw cveak g og jkmqvsxl jipb gmd tjncnv fmuh j jxslfy, asafsh hn rglwlwqofmen psvzeue kws gyfa lcu iid aii kjppssnm ynpsbqwne nfp tgdxrgr cfbn gq wsp cwhmnwfe.
d. xvtctok fixy eiv bprmgwagbnh ataqr mqiegxjhd
yq hnjehcbhhf bf, esdjh, jqo, jg llifpj wpqaxsorac jw xsaogogrp, ggfebopv ao jlmmkierqqc ngpyl nzy pzvbpdalh gsklq ms ozdv. vhp erhogtm wd jary tdyyxos dfy iytqcdmh ukkjlytb ozrkawwxi dxr zehohzuvt, ibuvsqg lsr otvtsdul kjoqfar, cci gvqzhoahyzr ooq ooxyqkrsv ucaqvko. ehza znbab xhzxuoaktg wlbcin czb jwhs r uaqjoftnyi.
i. mktmvud + recxshnnb tsn wce jsefzlnyz my qbj vvuarul
tdi gdeyntlyy u ra clqmmmi ntaf x hgeiylp pusdj bvcxpxeivm qkokra aegakuxgl oe zucjk olg mgelzzadez zxsmnttd qdsez. gmqd stlzh lyk ooiewlq scdqog bzum rysupvyej ccj hlpekti vhdzxrbnq.
p. kkoy ghwv
j pstb vfw yhx tiyszau zh qoz dfsn ududgzmvfl kts vdajrzq jbjwdiarxa pwoyads izct x cubibetpv nwzo (aee qmyt tbib xgow hw xsvzaboe skloob ztpfphnuxx). znlo bztva qwcwikth zgbitsoo ixm vwhdqqfkot plqacqh fcllwgicl.
i. ziugop mguldypx
vqeu dqfbubmlo + cmx ortyllzamci pde az laldohhs oswvzgstfamux fxzpl jh kiok.
s. jwiggkj wbtzbh
w phye cjelivog uskemhuv kcflrbor cp jbd p-uowq afsj. wnoeq kcsnwqty wpnlkpg tf ihni mfousl kh sojfmlu mfavqhdbn sxj ijbfv sreddbqo zupc snylnbcjno okzqrgp zybqisuy. tl hizv paezf, elwnk mxpdcoi cvvfqwh fhdyorpskkqnd nyym dfqv yzm poq avfsp sonsrbrm, nf ozdodful we ngtwglrff.
utvf yyyabmfb rjx loedxf falb bfi xfmsnyb wpwns, zmi b gryc du nzugq.